![]() |
市場調査レポート
商品コード
1560938
医薬品ろ過市場レポート:製品、手法、用途、運用規模、地域別、2024年~2032年Pharmaceutical Filtration Market Report by Product, Technique, Application, Scale of Operation, and Region 2024-2032 |
||||||
カスタマイズ可能
|
医薬品ろ過市場レポート:製品、手法、用途、運用規模、地域別、2024年~2032年 |
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の医薬品ろ過の市場規模は2023年に136億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに658億米ドルに達し、2024年から2032年の間に18.2%の成長率(CAGR)を示すと予測しています。バイオ医薬品に対する需要の高まり、厳しい規制基準、継続的な技術の進歩、医薬品の安全性への関心の高まりが市場成長を促進しています。
製薬およびバイオテクノロジー産業における支出の増加
製薬会社は研究開発、特にタンパク質精製や細胞培養などのプロセスで高度なろ過技術を必要とするバイオテクノロジーに多額の投資を行っています。例えば、Statistaによると、大手製薬企業は通常、収益の20%を研究開発に充てています。また、製薬会社のアストラゼネカは、2023年に処方薬収益の23%以上を研究開発に費やしています。さらに、モノクローナル抗体や組換えタンパク質を含むバイオ医薬品の増加により、製品の品質と収率を確保するために特殊なろ過方法が必要とされています。これらの要因が医薬品ろ過市場の成長をさらに後押ししています。
ジェネリック医薬品需要の増加
ジェネリック医薬品需要の増加は、医薬品ろ過市場の成長を牽引する顕著な要因の一つです。例えば、IMARCによると、世界のジェネリック医薬品市場規模は2023年に3,671億米ドルに達しました。今後、IMARC Groupは、2032年までに同市場が6,280億米ドルに達し、2024~2032年の成長率(CAGR)は5.96%に達すると予測しています。ジェネリック医薬品は世界の需要を満たすために大量に製造されるため、品質と規制遵守を確保するための効率的でスケーラブルなろ過プロセスが必要となります。これらの要因は、医薬品ろ過業界の予測にさらにプラスの影響を与えています。
慢性疾患の有病率の増加
慢性疾患の有病率の増加は、様々な医薬品に対する需要を増加させる。がん、糖尿病、喘息、COPD、関節炎などの慢性疾患に対処するために、新しい医薬品が導入されています。例えば、2023年12月、アストラゼネカ・ファーマ・インドは、HER2陽性乳がんの治療に使用されるトラスツズマブ・デルクステカン(別名エンヘルトゥ)を発売しました。新薬の上市には通常、市場の需要を満たすために生産量の拡大が必要となります。このような製造量の増加は、製品の品質と規制遵守を確保するためのろ過技術に対する需要の高まりと直結しています。こうした要因が、医薬品ろ過市場のシェアをさらに押し上げています。
The global pharmaceutical filtration market size reached US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 65.8 Billion by 2032, exhibiting a growth rate (CAGR) of 18.2% during 2024-2032. The escalating demand for biopharmaceuticals, stringent regulatory standards, ongoing technological advancements, and growing focus on drug safety are driving the market growth.
Rising Spending in Pharmaceutical and Biotechnological Industries
Pharmaceutical companies are investing heavily in research and development, particularly in biotechnology, which requires advanced filtration technologies for processes such as protein purification and cell culture. For instance, according to Statista, large pharmaceutical businesses typically dedicate 20% of their earnings to research and development. Also, AstraZeneca, a pharmaceutical company, spent more than 23% of its prescription drug earnings in 2023 on research and development. Moreover, the rise in biopharmaceuticals, including monoclonal antibodies and recombinant proteins, requires specialized filtration methods to ensure product quality and yield. These factors are further driving the pharmaceutical filtration market growth.
Increasing Demand for Generic Drugs
The increasing demand for generic drugs is one of the prominent factors driving the growth in the pharmaceutical filtration market. For instance, according to IMARC, the global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. Generic drugs are manufactured in large volumes to meet global demand, necessitating efficient and scalable filtration processes to ensure quality and regulatory compliance. These factors are further positively influencing the pharmaceutical filtration industry forecast.
Growing Prevalence of Chronic Diseases
The increased prevalence of chronic diseases increases the demand for a variety of medications. New medications are introduced to address chronic conditions, such as cancer, diabetes, asthma, COPD, and arthritis. For instance, in December 2023, AstraZeneca Pharma India launched Trastuzumab Deruxtecan, also known as Enhertu, which is used to treat HER2-positive breast cancer. Each new drug launch typically requires scaled-up production to meet the market demand. This increased manufacturing volume directly correlates with higher demand for filtration technologies to ensure product quality and regulatory compliance. These factors are further contributing to the pharmaceutical filtration market share.
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical filtration market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technique, application, and scale of operation.
Membrane filters currently hold the majority of the total market share
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the product. This includes membrane filters (MCE membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and others), prefilters and depth media (glass fiber filters, and PTFE fiber filters), single-use systems, cartridges and capsules, filter holders, filtration accessories, and others. According to the report, membrane filters hold the majority of the total market share.
According to the pharmaceutical filtration market outlook, membrane filters are essential in pharmaceutical manufacturing for processes, such as sterile filtration, virus filtration, and protein purification. They are used in bioprocessing applications for cell culture clarification, concentration, and separation of biomolecules. Moreover, in research laboratories, these are used for sample preparation, microbiological analysis, and particle removal in various scientific experiments. For instance, in December 2023, TeraPore Technologies, a nanofiltration membranes company, launched IsoBlock VF product line and IsoBlock PF Syringe Prefilter Device for parvovirus elimination from biopharmaceuticals. The IsoBlock PF Syringe Prefilter Device is an adsorptive membrane-based prefilter that removes undesired high-molecular-weight species from the feed prior to size-based virus removal.
Currently, microfiltration exhibits a clear dominance in the market
A detailed breakup and analysis of the pharmaceutical filtration market based on the technique has also been provided in the report. This includes microfiltration, ultrafiltration, crossflow filtration, nanofiltration, and others. According to the report, microfiltration exhibits a clear dominance in the market.
As per the pharmaceutical filtration market outlook, microfiltration is commonly used for sterile filtration to remove microorganisms and particles from pharmaceutical solutions and suspensions. This process is critical in preparing sterile drug products, such as injectables, ophthalmic solutions, and parenteral nutrition solutions. Moreover, it is used for clarification and particle removal in pharmaceutical manufacturing processes.
Final product processing currently accounts for the largest market share
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the application. This includes final product processing (active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccines and antibody processing, formulation and filling solutions, and viral clearance), raw material filtration (media buffer, pre-filtration, and bioburden testing), cell separation, water purification, and air purification. According to the report, final product processing accounts for the largest market share.
The demand for pharmaceutical filtration in final product processing is critical to ensure the safety, efficacy, and quality of pharmaceutical products before they reach consumers. Moreover, sterile filtration is essential to remove microorganisms and particles from pharmaceutical solutions and suspensions, ensuring they meet stringent sterility requirements. Final drug products, such as injectables (e.g., vaccines, antibiotics), ophthalmic solutions, and other sterile formulations, undergo sterile filtration to eliminate microbiological contaminants.
Currently, manufacturing scale exhibits a clear dominance in the market
The report has provided a detailed breakup and analysis of the pharmaceutical filtration market based on the scale of operation. This includes manufacturing scale, pilot scale, and research and development scale. According to the report, manufacturing scale exhibits a clear dominance in the market.
Pharmaceutical manufacturing operates on large scales to meet global demand for medications. This volume necessitates robust filtration processes to ensure consistent product quality and safety. Moreover, regulatory agencies impose strict guidelines on pharmaceutical manufacturers to ensure product safety, efficacy, and purity. Filtration processes are crucial for meeting these regulatory standards.
North America currently dominates the global market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical filtration.
According to the pharmaceutical filtration market statistics, the region has a strong presence of biopharmaceutical companies engaged in the production of biologics, vaccines, and biosimilars. For instance, in April 2024, Bavarian Nordic A/S, a fully integrated vaccine company, launched Jynneos, the only FDA-approved mpox vaccine in the United States. This sector requires advanced filtration technologies for processes like sterile filtration, virus filtration, and ultrafiltration/diafiltration (UF/DF). Moreover, continued investments in research and development by pharmaceutical companies and academic institutions fuel innovation in filtration technologies, supporting the market growth.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)